| PRECLINICAL | evidence | Thymosin beta4 and angiogenesis: modes of action and therapeutic potential. | Tbeta4 | Wound healing | 2007-01-01 |
| PRECLINICAL | evidence | Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells. | Thymosin β4 | — | 2007-01-01 |
| PRECLINICAL | evidence | Actin-sequestering protein, thymosin-beta-4 (TB4), inhibits caspase-3 activation in paclitaxel-induced tumor cell death. | Thymosin beta 4 | preclinical | 2007-01-01 |
| PRECLINICAL | evidence | Actin-sequestering protein, thymosin-beta-4 (TB4), inhibits caspase-3 activation in paclitaxel-induced tumor cell death. | TB4 | preclinical | 2007-01-01 |
| PRECLINICAL | evidence | Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. | Tbeta4 | Eye & vision health | 2007-01-01 |
| PRECLINICAL | evidence | Occurrence of thymosin beta4 in human breast cancer cells and in other cell types of the tumor microenvironment. | Thymosin beta 4 | — | 2007-01-01 |
| PRECLINICAL | evidence | Conjunctival expression of thymosin-beta4 in vernal keratoconjunctivitis. | Tbeta4 | Skin appearance & aging | 2006-12-20 |
| PRECLINICAL | evidence | [High incidence of fatal cytokine-related disease among children with sequelae of perinatal hypoxic-ischemic encephalopathy]. | TB4 | — | 2006-11-01 |
| PRECLINICAL | evidence | Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses. | Thymosin beta 4 | — | 2006-11-01 |
| PRECLINICAL | evidence | Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro. | Tbeta4 | — | 2006-11-01 |
| PRECLINICAL | evidence | Zyxin is upregulated in the nucleus by thymosin beta4 in SiHa cells. | Thymosin beta 4 | preclinical | 2006-10-15 |
| PRECLINICAL | evidence | Thymosin beta4 inhibits benzalkonium chloride-mediated apoptosis in corneal and conjunctival epithelial cells in vitro. | Tbeta4 | Mood & anxiety · preclinical | 2006-09-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. | Tbeta4 | — | 2006-07-01 |
| PRECLINICAL | evidence | The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. | Thymosin β4 | — | 2006-07-01 |
| PRECLINICAL | evidence | Thymosin beta4 and AcSDKP inhibit the proliferation of HL-60 cells and induce their differentiation and apoptosis. | Tbeta4 | — | 2006-06-01 |
| PRECLINICAL | evidence | ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. | Thymosin beta 4 | — | 2006-05-15 |
| PRECLINICAL | evidence | ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. | TB4 | — | 2006-05-15 |
| PRECLINICAL | evidence | Overexpression of thymosin beta-4 renders SW480 colon carcinoma cells more resistant to apoptosis triggered by FasL and two topoisomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively. | Tbeta4 | preclinical | 2006-05-01 |
| PRECLINICAL | evidence | Profilin: emerging concepts and lingering misconceptions. | Thymosin beta 4 | — | 2006-04-01 |
| PRECLINICAL | evidence | Thymosin beta10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells. | Thymosin beta 4 | preclinical | 2006-04-01 |
| PRECLINICAL | evidence | Colorectal carcinoma: from tumorigenesis to treatment. | Thymosin beta 4 | — | 2006-03-01 |
| PRECLINICAL | evidence | Analysis on heat stress-induced hyperphosphorylation of stathmin at serine 37 in Jurkat cells by means of two-dimensional gel electrophoresis and tandem mass spectrometry. | Thymosin beta 4 | — | 2006-02-17 |
| PRECLINICAL | evidence | Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts. | Thymosin beta 4 | Skin appearance & aging · preclinical | 2006-01-15 |
| PRECLINICAL | evidence | Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential. | Tbeta4 | Inflammation · preclinical | 2006-01-13 |
| PRECLINICAL | evidence | Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction. | Thymosin beta 4 | — | 2006-01-01 |
| PRECLINICAL | evidence | Actin-bound structures of Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly. | Tbeta4 | — | 2005-11-15 |
| PRECLINICAL | evidence | [Regenerative medicine of skeletal muscle]. | Thymosin beta 4 | Muscle growth & preservation | 2005-11-01 |
| PRECLINICAL | evidence | Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. | Thymosin beta 4 | Eye & vision health · preclinical | 2005-10-01 |
| PRECLINICAL | evidence | Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. | Tbeta4 | Wound healing | 2005-09-01 |
| PRECLINICAL | evidence | Effect of thymosin beta15 on the branching of developing neurons. | Tbeta4 | — | 2005-05-27 |
| PRECLINICAL | evidence | Targeted biomarker detection via whole protein ion trap tandem mass spectrometry: thymosin beta4 in a human lung cancer cell line. | Thymosin beta 4 | preclinical | 2005-04-01 |
| PRECLINICAL | evidence | Molecular cloning and structural characterization of the functional human thymosin beta4 gene. | Tbeta4 | — | 2005-04-01 |
| PRECLINICAL | evidence | Identification of the positive and negative cis-elements involved in modulating the constitutive expression of mouse thymosin beta4 gene. | Thymosin beta 4 | — | 2005-04-01 |
| PRECLINICAL | evidence | Roles of thymosins in cancers and other organ systems. | Tbeta4 | — | 2005-03-01 |
| PRECLINICAL | evidence | Top-down identification of endogenous peptides up to 9 kDa in cerebrospinal fluid and brain tissue by nanoelectrospray quadrupole time-of-flight tandem mass spectrometry. | Thymosin beta 4 | — | 2005-02-01 |
| PRECLINICAL | evidence | [Expression of thymosin beta 4 mRNA expression in keloid tissues and fibroblasts cultured from keloid and its significance]. | Thymosin beta 4 | Skin appearance & aging · preclinical | 2005-02-01 |
| PRECLINICAL | evidence | Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: possible insights from emerging technology. | Thymosin beta 4 | preclinical | 2005-02-01 |
| PRECLINICAL | evidence | Thymosin beta(10) inhibits angiogenesis and tumor growth by interfering with Ras function. | Thymosin beta 4 | — | 2005-01-01 |
| PRECLINICAL | evidence | A rapid and sensitive assay for quantification of siRNA efficiency and specificity. | Tbeta4 | — | 2005-01-01 |
| PRECLINICAL | evidence | [The clinical significance of thymosin beta4 expression in human non-small cell lung cancer]. | Tbeta4 | — | 2004-12-20 |
| PRECLINICAL | evidence | Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. | Thymosin β4 | — | 2004-12-15 |
| PRECLINICAL | evidence | A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. | Thymosin beta 4 | Immune function · preclinical | 2004-12-01 |
| PRECLINICAL | evidence | Selective nonsteroidal anti-inflammatory drugs induce thymosin beta-4 and alter actin cytoskeletal organization in human colorectal cancer cells. | Thymosin beta 4 | Inflammation · preclinical | 2004-12-01 |
| PRECLINICAL | evidence | Regenerative medicine: Prometheus unbound. | Thymosin beta 4 | Wound healing | 2004-11-25 |
| PRECLINICAL | evidence | Nuclear localisation of the G-actin sequestering peptide thymosin beta4. | Thymosin beta 4 | Wound healing | 2004-10-15 |
| PRECLINICAL | evidence | A comparative analysis of RNA targeting strategies in the thymosin beta 4 gene. | Tbeta4 | — | 2004-09-24 |
| PRECLINICAL | evidence | Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins. | Tbeta4 | — | 2004-09-15 |
| PRECLINICAL | evidence | Overexpression of the thymosin beta-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. | Tbeta4 | preclinical | 2004-08-26 |
| PRECLINICAL | evidence | Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains. | Thymosin beta 4 | — | 2004-08-24 |
| PRECLINICAL | evidence | Effects of profilin and thymosin beta4 on the critical concentration of actin demonstrated in vitro and in cell extracts with a novel direct assay. | Thymosin beta 4 | — | 2004-08-06 |